Experience

Calhoun Community College

• Higher Education
• 400 - 500 Employee

• Chair, Department of Natural Sciences

  • May 2014 - Present

  Natural Sciences Department Chair for Calhoun's Huntsville campus from 5/14 to 8/16; Chair on the Decatur Campus from 8/16 to present.

• Biology and Biotechnology Instructor

  • Aug 2007 - Present

  I teach Biotechnology, Microbiology, and Anatomy & Physiology courses to community college students in both traditional and online formats. Our biotechnology program prepares students to work in area biotech companies and research laboratories. Most of my Microbiology and A&P students are working toward careers in nursing and other health sciences professions.



University of Alabama at Birmingham

• Higher Education
• 700 & Above Employee

• Research Assistant Professor, Department of Cell Biology

  • Aug 2003 - Aug 2007

  While holding this position, I worked on the development of a transgenic rat model for HIV pathogenesis with the goal of making small animal studies with the virus more representative of the human situation. I also taught virology lectures to graduate, medical, dental, and optometry students and worked with graduate students on dissertation research projects in the laboratory. While holding this position, I worked on the development of a transgenic rat model for HIV pathogenesis with the goal of making small animal studies with the virus more representative of the human situation. I also taught virology lectures to graduate, medical, dental, and optometry students and worked with graduate students on dissertation research projects in the laboratory.



Replicon Neurotherapeutics, Inc.

• Co-founder and Director of Research and Pharmaceutical Development

  • May 1998 - Jul 2003

  I was a part-time and later full-time employee of a startup biotechnology company focused on the development of recombinant poliovirus replicons as cancer therapeutics and gene therapy vectors. The position included basic research and development work, including smaller scale manufacturing of the recombinant polioviruses, acting as a liaison with patent attorneys, and working with other members of the company to secure venture capital investments. The company closed in July 2003. I was a part-time and later full-time employee of a startup biotechnology company focused on the development of recombinant poliovirus replicons as cancer therapeutics and gene therapy vectors. The position included basic research and development work, including smaller scale manufacturing of the recombinant polioviruses, acting as a liaison with patent attorneys, and working with other members of the company to secure venture capital investments. The company closed in July 2003.

• Research Assistant Professor, Department of Microbiology

  • Mar 1996 - May 2001

  Research work focused on the development of recombinant polioviruses as gene therapy vectors and anti-cancer agents. Research work focused on the development of recombinant polioviruses as gene therapy vectors and anti-cancer agents.



University of North Carolina at Chapel Hill

• Research
• 1 - 100 Employee

• Postdoctoral Fellow

  • Mar 1994 - Mar 1996

  Postdoctoral research on the mechanism of Adeno Associated Virus integration in the laboratory of Dr. Jude Samulski, Director of the Gene Therapy Center. Postdoctoral research on the mechanism of Adeno Associated Virus integration in the laboratory of Dr. Jude Samulski, Director of the Gene Therapy Center.